Cabinet Becker Associs competitive analysis

Explore patent oppositions filed by Cabinet Becker Associs against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jun 25, 2026
Patent NumberTitleApplicantOpposition Date
Nemolizumab In The Treatment Of Atopic Dermatitis With Moderate To Severe ExcoriationCHUGAI SEIYAKU KABUSHIKI KAISHAApr 30, 2026
Nutritional Composition For Improving Immune FitnessNUTRICIAOct 29, 2025
Method For In Vitro Production Of Hyaline Cartilage TissueVANARIXJul 16, 2025
Process For Enzymatic Oil DegummingDSM ASSETSJul 8, 2025

Latest PTAB cases involving Cabinet Becker Associs

Discover the latest PTAB cases involving Cabinet Becker Associs, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Cabinet Becker Associs with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jun 25, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CABINET BECKER ASSOCIS4 - - -
CHUGAI SEIYAKU KABUSHIKI KAISHA396 - 1
DSM ASSETS21112 - 15
GALDERMA HOLDING23 - -